{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:23:23Z","timestamp":1767986603114,"version":"3.49.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.ncl.2011.01.008","type":"journal-article","created":{"date-parts":[[2011,3,25]],"date-time":"2011-03-25T09:03:16Z","timestamp":1301043796000},"page":"449-463","source":"Crossref","is-referenced-by-count":60,"title":["Symptomatic Management in Multiple Sclerosis"],"prefix":"10.1016","volume":"29","author":[{"given":"Lawrence M.","family":"Samkoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ncl.2011.01.008_bib1","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1586\/14737175.7.9.1213","article-title":"Multiple sclerosis symptom management","volume":"7","author":"Boissy","year":"2007","journal-title":"Expert Rev Neurother"},{"issue":"7","key":"10.1016\/j.ncl.2011.01.008_bib2","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1177\/1352458506075651","article-title":"The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines","volume":"13","author":"de Seze","year":"2007","journal-title":"Mult Scler"},{"issue":"1008","key":"10.1016\/j.ncl.2011.01.008_bib3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/jnnp.2008.159178","article-title":"A\u00a0UK consensus on the management of the bladder in multiple sclerosis","volume":"85","author":"Fowler","year":"2009","journal-title":"Postgrad Med J"},{"issue":"Suppl 4","key":"10.1016\/j.ncl.2011.01.008_bib4","doi-asserted-by":"crossref","first-page":"S352","DOI":"10.1007\/s10072-008-1042-y","article-title":"Diagnosis and therapy for neurogenic bladder dysfunctions in multiple sclerosis patients","volume":"29","author":"Del Popolo","year":"2008","journal-title":"Neurol Sci"},{"issue":"5","key":"10.1016\/j.ncl.2011.01.008_bib5","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ana.21209","article-title":"Botulinum injections for the treatment of bladder symptoms of multiple sclerosis","volume":"62","author":"Kalsi","year":"2007","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2011.01.008_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2005.00431.x","article-title":"Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis","volume":"112","author":"Bosma","year":"2005","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"10.1016\/j.ncl.2011.01.008_bib7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00042737-200104000-00025","article-title":"Pathophysiology and management of bowel dysfunction in multiple sclerosis","volume":"13","author":"Wiesel","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.ncl.2011.01.008_bib8","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/0016-5085(90)91087-M","article-title":"Prevalence of bowel dysfunction in multiple sclerosis. A population survey","volume":"98","author":"Hinds","year":"1990","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ncl.2011.01.008_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.12968\/bjon.2010.19.4.46783","article-title":"Bowel problems and coping strategies in people with multiple sclerosis","volume":"19","author":"Norton","year":"2010","journal-title":"Br J Nurs"},{"issue":"8","key":"10.1016\/j.ncl.2011.01.008_bib10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.12968\/bjcn.2006.11.8.21665","article-title":"Management of bowel dysfunction in people with multiple sclerosis","volume":"11","author":"Bywater","year":"2006","journal-title":"Br J Community Nurs"},{"issue":"2","key":"10.1016\/j.ncl.2011.01.008_bib11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/jnnp.69.2.240","article-title":"Gut focused behavioural treatment (biofeedback) for constipation and faecal incontinence in multiple sclerosis","volume":"69","author":"Wiesel","year":"2000","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.ncl.2011.01.008_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ncpuro1298","article-title":"Sexual dysfunction in patients with multiple sclerosis: a multidisciplinary approach to evaluation and management","volume":"6","author":"Fletcher","year":"2009","journal-title":"Nat Clin Pract Urol"},{"issue":"2","key":"10.1016\/j.ncl.2011.01.008_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1191\/135248506ms1253oa","article-title":"Multiple sclerosis patients with and without sexual dysfunction: are there any differences?","volume":"12","author":"Demirkiran","year":"2006","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.ncl.2011.01.008_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1586\/14737175.9.3.341","article-title":"Sexual dysfunction in multiple sclerosis","volume":"9","author":"Kessler","year":"2009","journal-title":"Expert Rev Neurother"},{"issue":"8","key":"10.1016\/j.ncl.2011.01.008_bib15","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1177\/1352458508093619","article-title":"The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis","volume":"14","author":"Tepavcevic","year":"2008","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.ncl.2011.01.008_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/1352458506071134","article-title":"Sexual dysfunction in females with multiple sclerosis: quantitative sensory testing","volume":"13","author":"Gruenwald","year":"2007","journal-title":"Mult Scler"},{"issue":"5","key":"10.1016\/j.ncl.2011.01.008_bib17","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/jnnp.2004.038695","article-title":"A\u00a0double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis","volume":"76","author":"Fowler","year":"2005","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.ncl.2011.01.008_bib18","first-page":"252","article-title":"Evaluation of the safety and efficacy of sildenafil citrate for erectile dysfunction in men with multiple sclerosis: a double-blind, placebo controlled, randomized study","volume":"181","author":"Safarinejad","year":"2009","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.ncl.2011.01.008_bib19","first-page":"1189","article-title":"Efficacy of sildenafil in the treatment of female sexual dysfunction due to multiple sclerosis","volume":"171","author":"Dasgupta","year":"2004","journal-title":"J\u00a0Urol"},{"issue":"12","key":"10.1016\/j.ncl.2011.01.008_bib20","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1474-4422(08)70259-X","article-title":"Cognitive impairment in multiple sclerosis","volume":"7","author":"Chiaravalloti","year":"2008","journal-title":"Lancet Neurol"},{"issue":"Suppl 2","key":"10.1016\/j.ncl.2011.01.008_bib21","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1007\/s10072-010-0376-4","article-title":"Cognitive impairment in early stages of multiple sclerosis","volume":"31","author":"Amato","year":"2010","journal-title":"Neurol Sci"},{"issue":"5","key":"10.1016\/j.ncl.2011.01.008_bib22","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1212\/WNL.41.5.685","article-title":"Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction","volume":"41","author":"Rao","year":"1991","journal-title":"Neurology"},{"issue":"Suppl 2","key":"10.1016\/j.ncl.2011.01.008_bib23","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.1007\/s10072-010-0367-5","article-title":"MRI and cognition in multiple sclerosis","volume":"31","author":"Filippi","year":"2010","journal-title":"Neurol Sci"},{"issue":"9","key":"10.1016\/j.ncl.2011.01.008_bib24","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archneurol.2009.190","article-title":"Multiple sclerosis with predominant, severe cognitive impairment","volume":"66","author":"Staff","year":"2009","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2011.01.008_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/rheumatology\/18.3.153","article-title":"Intellectual impairment in multiple sclerosis and its relation to functional abilities","volume":"18","author":"Staples","year":"1979","journal-title":"Rheumatol Rehabil"},{"issue":"5","key":"10.1016\/j.ncl.2011.01.008_bib26","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1212\/WNL.41.5.692","article-title":"Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning","volume":"41","author":"Rao","year":"1991","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2011.01.008_bib27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1017\/S1355617706060723","article-title":"Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS)","volume":"12","author":"Benedict","year":"2006","journal-title":"J\u00a0Int Neuropsychol Soc"},{"issue":"9","key":"10.1016\/j.ncl.2011.01.008_bib28","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1212\/01.WNL.0000142989.09633.5A","article-title":"Donepezil improved memory in multiple sclerosis in a randomized clinical trial","volume":"63","author":"Krupp","year":"2004","journal-title":"Neurology"},{"issue":"1\/2","key":"10.1016\/j.ncl.2011.01.008_bib29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jns.2005.08.021","article-title":"Effects of donepezil on memory and cognition in multiple sclerosis","volume":"245","author":"Christodoulou","year":"2006","journal-title":"J\u00a0Neurol Sci"},{"issue":"4","key":"10.1016\/j.ncl.2011.01.008_bib30","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1017\/S0317167100009148","article-title":"Effects of rivastigmine on memory and cognition in multiple sclerosis","volume":"35","author":"Shaygannejad","year":"2008","journal-title":"Can J Neurol Sci"},{"issue":"19","key":"10.1016\/j.ncl.2011.01.008_bib31","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000342388.73185.80","article-title":"Memantine induces reversible neurologic impairment in patients with MS","volume":"72","author":"Villoslada","year":"2009","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ncl.2011.01.008_bib32","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/1352458510367662","article-title":"Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial","volume":"16","author":"Lovera","year":"2010","journal-title":"Mult Scler"},{"issue":"4","key":"10.1016\/j.ncl.2011.01.008_bib33","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.apmr.2007.10.019","article-title":"Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: a review of the literature","volume":"89","author":"O\u2019Brien","year":"2008","journal-title":"Arch Phys Med Rehabil"},{"issue":"1","key":"10.1016\/j.ncl.2011.01.008_bib34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pain.2007.08.024","article-title":"Pain associated with multiple sclerosis: Systematic review and proposed classification","volume":"137","author":"O\u2019Connor","year":"2008","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.ncl.2011.01.008_bib35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2165\/00023210-200822040-00003","article-title":"Current management of pain associated with multiple sclerosis","volume":"22","author":"Pollmann","year":"2008","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.ncl.2011.01.008_bib36","first-page":"101","article-title":"Pain in multiple sclerosis: Prevalence, mechanisms, types and treatment","volume":"50","author":"Bermejo","year":"2010","journal-title":"Rev Neurol"},{"issue":"8","key":"10.1016\/j.ncl.2011.01.008_bib37","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/archneur.60.8.1089","article-title":"Pain in patients with multiple sclerosis: a population-based study","volume":"60","author":"Svendsen","year":"2003","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2011.01.008_bib38","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/1352458506071346","article-title":"The scope and nature of pain in persons with multiple sclerosis","volume":"12","author":"Ehde","year":"2006","journal-title":"Mult Scler"},{"issue":"6","key":"10.1016\/j.ncl.2011.01.008_bib39","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1191\/1352458503ms939oa","article-title":"Chronic pain in a large community sample of persons with multiple sclerosis","volume":"9","author":"Ehde","year":"2003","journal-title":"Mult Scler"},{"issue":"8","key":"10.1016\/j.ncl.2011.01.008_bib40","first-page":"614","article-title":"Chronic pain in multiple sclerosis: prevalence, characteristics, and impact on quality of life in an australian community cohort","volume":"8","author":"Khan","year":"2007","journal-title":"J\u00a0Pain"},{"issue":"3","key":"10.1016\/j.ncl.2011.01.008_bib41","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.pain.2008.12.026","article-title":"Trigeminal neuralgia and pain related to multiple sclerosis","volume":"143","author":"Cruccu","year":"2009","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.ncl.2011.01.008_bib42","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1468-1331.2008.02185.x","article-title":"AAN-EFNS guidelines on trigeminal neuralgia management","volume":"15","author":"Cruccu","year":"2008","journal-title":"Eur J Neurol"},{"issue":"14","key":"10.1016\/j.ncl.2011.01.008_bib43","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1212\/WNL.0b013e3181bacfb4","article-title":"Gamma knife radiosurgery for multiple sclerosis-related trigeminal neuralgia","volume":"73","author":"Zorro","year":"2009","journal-title":"Neurology"},{"issue":"11 Suppl 5","key":"10.1016\/j.ncl.2011.01.008_bib44","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1212\/WNL.63.11_suppl_5.S35","article-title":"Strategies for managing the side effects of treatments for multiple sclerosis","volume":"63","author":"Langer-Gould","year":"2004","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ncl.2011.01.008_bib45","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A\u00a0randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ncl.2011.01.008_bib46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/09540261003589323","article-title":"The neuropsychiatry of multiple sclerosis: Focus on disorders of mood, affect and behaviour","volume":"22","author":"Paparrigopoulos","year":"2010","journal-title":"Int Rev Psychiatry"},{"issue":"4","key":"10.1016\/j.ncl.2011.01.008_bib47","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/jnnp.2004.054635","article-title":"Depression in multiple sclerosis: a review","volume":"76","author":"Siegert","year":"2005","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.ncl.2011.01.008_bib48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1352458506071161","article-title":"Anxiety disorders and their clinical correlates in multiple sclerosis patients","volume":"13","author":"Korostil","year":"2007","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.ncl.2011.01.008_bib49","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1191\/1352458505ms1162oa","article-title":"The Goldman consensus statement on depression in multiple sclerosis","volume":"11","author":"Goldman Consensus Group","year":"2005","journal-title":"Mult Scler"},{"issue":"5","key":"10.1016\/j.ncl.2011.01.008_bib50","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1177\/1352458507072384","article-title":"Treatment of depression in people who have multiple sclerosis","volume":"13","author":"Sollom","year":"2007","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.ncl.2011.01.008_bib51","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.eurpsy.2005.09.013","article-title":"Psychiatric side effects of interferon-beta in multiple sclerosis","volume":"21","author":"Goeb","year":"2006","journal-title":"Eur Psychiatry"},{"issue":"4","key":"10.1016\/j.ncl.2011.01.008_bib52","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1212\/WNL.43.4.655","article-title":"Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB multiple sclerosis study group","volume":"43","year":"1993","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.ncl.2011.01.008_bib53","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","article-title":"Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS study group","volume":"343","author":"Jacobs","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ncl.2011.01.008_bib54","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/1352458507082942","article-title":"Anti-depressant use in association with interferon and glatiramer acetate treatment in multiple sclerosis","volume":"14","author":"Patten","year":"2008","journal-title":"Mult Scler"},{"issue":"4","key":"10.1016\/j.ncl.2011.01.008_bib55","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.psc.2007.07.003","article-title":"Psychiatric issues in multiple sclerosis","volume":"30","author":"Chwastiak","year":"2007","journal-title":"Psychiatr Clin North Am"},{"issue":"4","key":"10.1016\/j.ncl.2011.01.008_bib56","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.apnu.2007.02.008","article-title":"Depression in multiple sclerosis: a longitudinal analysis","volume":"21","author":"Beal","year":"2007","journal-title":"Arch Psychiatr Nurs"},{"issue":"10","key":"10.1016\/j.ncl.2011.01.008_bib57","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1136\/jnnp.2004.056747","article-title":"Suicide among danes with multiple sclerosis","volume":"76","author":"Bronnum-Hansen","year":"2005","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.ncl.2011.01.008_bib58","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1212\/WNL.41.8.1193","article-title":"Cause of death in patients attending multiple sclerosis clinics","volume":"41","author":"Sadovnick","year":"1991","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ncl.2011.01.008_bib59","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/jnnp.55.7.542","article-title":"Suicide and multiple sclerosis: An epidemiological investigation","volume":"55","author":"Stenager","year":"1992","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.ncl.2011.01.008_bib60","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.apmr.2006.04.021","article-title":"Suicidal ideation in multiple sclerosis","volume":"87","author":"Turner","year":"2006","journal-title":"Arch Phys Med Rehabil"},{"issue":"5","key":"10.1016\/j.ncl.2011.01.008_bib61","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/WNL.59.5.674","article-title":"An examination of suicidal intent in patients with multiple sclerosis","volume":"59","author":"Feinstein","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2011.01.008_bib62","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"10.1016\/j.ncl.2011.01.008_bib63","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1352458506070926","article-title":"Screening for depression among patients with multiple sclerosis: two questions may be enough","volume":"13","author":"Mohr","year":"2007","journal-title":"Mult Scler"},{"issue":"11","key":"10.1016\/j.ncl.2011.01.008_bib64","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1176\/ajp.147.11.1493","article-title":"Antidepressant pharmacotherapy of depression associated with multiple sclerosis","volume":"147","author":"Schiffer","year":"1990","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.ncl.2011.01.008_bib65","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1037\/0022-006X.69.6.942","article-title":"Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis","volume":"69","author":"Mohr","year":"2001","journal-title":"J\u00a0Consult Clin Psychol"},{"issue":"8","key":"10.1016\/j.ncl.2011.01.008_bib66","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1177\/1352458507077864","article-title":"Antidepressant use in multiple sclerosis: epidemiologic study of a large community sample","volume":"13","author":"Cetin","year":"2007","journal-title":"Mult Scler"},{"issue":"4","key":"10.1016\/j.ncl.2011.01.008_bib67","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.53.4.743","article-title":"Quantitative assessment of motor fatigue and strength in MS","volume":"53","author":"Schwid","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2011.01.008_bib68","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1477-7525-7-68","article-title":"The impact of regular physical activity on fatigue, depression and quality of life in persons with multiple sclerosis","volume":"7","author":"Stroud","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ncl.2011.01.008_bib69","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archneur.1988.00520280085020","article-title":"Fatigue in multiple sclerosis","volume":"45","author":"Krupp","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2011.01.008_bib70","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1212\/01.WNL.0000070183.30517.2F","article-title":"A\u00a0randomized controlled study of the acute and chronic effects of cooling therapy for MS","volume":"60","author":"Schwid","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2011.01.008_bib71","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ana.410390405","article-title":"Impact of aerobic training on fitness and quality of life in multiple sclerosis","volume":"39","author":"Petajan","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2011.01.008_bib72","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1017\/S0317167100026603","article-title":"The Canadian MS Research Group. A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis","volume":"14","year":"1987","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.ncl.2011.01.008_bib73","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/archneur.1989.00520420096030","article-title":"Amantadine treatment of fatigue associated with multiple sclerosis","volume":"46","author":"Cohen","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2011.01.008_bib74","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1212\/WNL.45.11.1956","article-title":"Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo","volume":"45","author":"Krupp","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2011.01.008_bib75","first-page":"983","article-title":"Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study","volume":"249","author":"Zifko","year":"2002","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2011.01.008_bib76","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/jnnp.72.2.179","article-title":"Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study","volume":"72","author":"Rammohan","year":"2002","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2011.01.008_bib77","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1212\/01.WNL.0000158272.27070.6A","article-title":"Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study","volume":"64","author":"Stankoff","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2011.01.008_bib78","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001332","article-title":"Anti-spasticity agents for multiple sclerosis","volume":"4","author":"Shakespeare","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ncl.2011.01.008_bib79","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1212\/WNL.28.11.1094","article-title":"Baclofen for spasticity in multiple sclerosis. Double-blind crossover and three-year study","volume":"28","author":"Feldman","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2011.01.008_bib80","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1212\/WNL.41.11.1829","article-title":"High-dose oral baclofen: experience in patients with multiple sclerosis","volume":"41","author":"Smith","year":"1991","journal-title":"Neurology"},{"issue":"11 Suppl 9","key":"10.1016\/j.ncl.2011.01.008_bib81","first-page":"70","article-title":"United Kingdom Tizanidine Trial Group. A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis","volume":"44","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2011.01.008_bib82","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1001\/archneur.1997.00550180049011","article-title":"Relationship of the antispasticity effect of tizanidine to plasma concentration in patients with multiple sclerosis","volume":"54","author":"Nance","year":"1997","journal-title":"Arch Neurol"},{"issue":"11 Suppl 9","key":"10.1016\/j.ncl.2011.01.008_bib83","first-page":"34","article-title":"US Tizanidine Study Group. Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial","volume":"44","author":"Smith","year":"1994","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ncl.2011.01.008_bib84","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1600-0404.1975.tb01366.x","article-title":"A\u00a0double-blind trial with baclofen (Lioresal) and diazepam in spasticity due to multiple sclerosis","volume":"51","author":"From","year":"1975","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ncl.2011.01.008_bib85","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0003-9993(97)90168-4","article-title":"Gabapentin for relief of upper motor neuron symptoms in multiple sclerosis","volume":"78","author":"Mueller","year":"1997","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.ncl.2011.01.008_bib86","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0003-9993(00)90135-7","article-title":"Gabapentin effect on spasticity in multiple sclerosis: a placebo-controlled, randomized trial","volume":"81","author":"Cutter","year":"2000","journal-title":"Arch Phys Med Rehabil"},{"issue":"Suppl 4","key":"10.1016\/j.ncl.2011.01.008_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1331.2006.01648.x","article-title":"The structure and mode of action of different botulinum toxins","volume":"13","author":"Dolly","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ncl.2011.01.008_bib88","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/0269215507072772","article-title":"Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis","volume":"21","author":"Giovannelli","year":"2007","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.ncl.2011.01.008_bib89","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/jnnp.68.6.707","article-title":"Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study","volume":"68","author":"Hyman","year":"2000","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2011.01.008_bib90","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJM198906083202303","article-title":"Intrathecal baclofen for severe spinal spasticity","volume":"320","author":"Penn","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2011.01.008_bib91","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1136\/jnnp.2003.014282","article-title":"Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin","volume":"75","author":"Zahavi","year":"2004","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2011.01.008_bib92","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clineuro.2004.09.007","article-title":"Functional outcome of intrathecal baclofen administration for severe spasticity","volume":"107","author":"Boviatsis","year":"2005","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.ncl.2011.01.008_bib93","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005029.pub2","article-title":"Treatment for ataxia in multiple sclerosis","volume":"1","author":"Mills","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ncl.2011.01.008_bib94","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1212\/WNL.35.9.1374","article-title":"Controlled trial of isoniazid therapy for severe postural cerebellar tremor in multiple sclerosis","volume":"35","author":"Hallett","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2011.01.008_bib95","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1212\/WNL.35.12.1772","article-title":"Isoniazid for tremor in multiple sclerosis: a controlled trial","volume":"35","author":"Duquette","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2011.01.008_bib96","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/archneur.1984.04050150058017","article-title":"Pharmacologic trials in the treatment of cerebellar tremor","volume":"41","author":"Koller","year":"1984","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2011.01.008_bib97","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jocn.2004.09.008","article-title":"Thalamotomy versus thalamic stimulation for multiple sclerosis tremor","volume":"12","author":"Bittar","year":"2005","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.ncl.2011.01.008_bib98","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM200002173420703","article-title":"A\u00a0comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor","volume":"342","author":"Schuurman","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2011.01.008_bib99","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/mds.22059","article-title":"Long-term follow-up of thalamic stimulation versus thalamotomy for tremor suppression","volume":"23","author":"Schuurman","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2011.01.008_bib100","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/1352458506069538","article-title":"Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study","volume":"13","author":"Goodman","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.ncl.2011.01.008_bib101","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1212\/01.wnl.0000326213.89576.0e","article-title":"Dose comparison trial of sustained-release fampridine in multiple sclerosis","volume":"71","author":"Goodman","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2011.01.008_bib102","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0140-6736(09)60442-6","article-title":"Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial","volume":"373","author":"Goodman","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2011.01.008_bib103","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/ana.22240","article-title":"A\u00a0phase 3 trial of extended release oral dalfampridine in multiple sclerosis","volume":"68","author":"Goodman","year":"2010","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2011.01.008_bib104","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1212\/WNL.60.1.31","article-title":"Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12)","volume":"60","author":"Hobart","year":"2003","journal-title":"Neurology"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861911000090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861911000090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T22:25:18Z","timestamp":1543875918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861911000090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":104,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0733861911000090"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2011.01.008","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}